Recursion Pharmaceuticals Inc. RXRX shares are trending on Friday. Shares of the Utah-based clinical-stage biotechnology company edged 0.24% higher to $4.17 after the bell on Thursday, following a ...

Together AI builds an agentic compiler to try and bring recursive self improvement capabilities to open source models.

Recursion Pharma launches a $200M equity offering and reports a Sanofi milestone but is rated a Hold on limited near-term catalysts. Click for more on RXRX.

A $10 million Sanofi milestone drove revenue 258% higher year over year, beating expectations and showing the AI platform ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can sometimes be written surprisingly concisely using functions.A prime example ...

When I hear the word "recursion," I think of recursive processing (recursive).In the world of computers, recursive processing ...

Salt Lake City, UT, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and ...

The companies Summit Therapeutics, Dren Bio, and Lycia Therapeutics bagged the biggest biotech funding rounds overall in October 2026.

This is Part Two, of our interview with Chat-GPT 5.6. As with Part One, I did not ask GPT questions based on my own interests or, in many cases, not knowing what I thought the answers would or should ...

Anthropic's pre-IPO filing shows internal Claude usage now exceeds its cash payroll and the model writes over 90% of its code — the clearest ...

Claude formally proved security properties in the compiled code of 123 open-source libraries. Along the way, it found bugs ...